Výsledky vyhledávání

The limited state of technology assessment for medical devices: facing the issues

Autor: S D, Ramsey, B R, Luce, R, Deyo, G, Franklin

Publikováno v: The American journal of managed care.

Medical devices are an integral part of clinical practice and account for a substantial proportion of the national health budget. Clinical testing and regulation of medical devices, however, is vastly different from and inferior to the testing and re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e7e7d1a149e5ba6ac1150d4f0362b015
https://pubmed.ncbi.nlm.nih.gov/10185994

Zobrazit plný text záznamu

Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group

Autor: M C, Weinstein, J E, Siegel, A M, Garber, J, Lipscomb, B R, Luce, W G, Manning, G W, Torrance

Publikováno v: Health economics. 6(5)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1c74686afea156e094be45590803e11a
https://pubmed.ncbi.nlm.nih.gov/9353652

Zobrazit plný text záznamu

When is a cost-effectiveness claim valid? How much should the FDA care?

Autor: B R, Luce, A L, Hillman

Publikováno v: The American journal of managed care. 3(11)

Federal law requires the Food and Drug Administration (FDA) to regulate the promotional claims of prescription drugs and certain devices. Standards of evidence for claims of safety and therapeutic efficacy are rigorous because inappropriate product u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::51087c08009f5760427cc48cd9de9487
https://pubmed.ncbi.nlm.nih.gov/10178464

Zobrazit plný text záznamu

Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine

Autor: J E, Siegel, G W, Torrance, L B, Russell, B R, Luce, M C, Weinstein, M R, Gold

Publikováno v: PharmacoEconomics. 11(2)

This article reports the recommendations of the Panel on Cost Effectiveness in Health and Medicine, sponsored by the US Public Health Service, on standardised methods for conducting cost-effectiveness analyses. Although not expressly directed at anal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9be6c56f213beb3ff51d93816f38efd8
https://pubmed.ncbi.nlm.nih.gov/10172935

Zobrazit plný text záznamu

The view from managed care pharmacy

Autor: B R, Luce, C A, Lyles, A M, Rentz

Publikováno v: Health affairs (Project Hope). 15(4)

This stratified, national telephone survey of fifty-one managed care organizations concerns the perspectives of managed care pharmacy directors on pharmacoeconomics, disease management, and the roles of the pharmaceutical industry and the Food and Dr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f0feb682029b60ffff77213d4d1100b0
https://pubmed.ncbi.nlm.nih.gov/8991272

Zobrazit plný text záznamu

Working toward a common currency: is standardization of cost-effectiveness analysis possible?

Autor: B R, Luce

Publikováno v: Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 10

The field of cost-effectiveness has been quietly evolving for several decades. However, concerns and controversies have recently surfaced regarding the lack of standardization with which cost-effectiveness analyses are performed. This attention is du

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9b4536496dee9f1cc421765025ee9bb7
https://pubmed.ncbi.nlm.nih.gov/7493194

Zobrazit plný text záznamu

Methods of pharmacoeconomic evaluation of new medical treatments in psychiatry

Autor: D A, Revicki, B R, Luce

Publikováno v: Psychopharmacology bulletin. 31(1)

There is concern in developed countries about the increasing cost of health care. Developers of new psychopharmacologic agents are asked to demonstrate cost-effectiveness as well as safety and efficacy before widespread use is encouraged. Pharmacoeco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e24cd31e12084ba5a5e0a089603fa5e3
https://pubmed.ncbi.nlm.nih.gov/7675990

Zobrazit plný text záznamu

Medical care and cost outcomes after pentoxifylline treatment for peripheral arterial disease

Autor: A, Stergachis, S, Sheingold, B R, Luce, B M, Psaty, D A, Revicki

Publikováno v: Archives of internal medicine. 152(6)

We assessed the medical outcomes and costs associated with the pharmacologic treatment of patients with peripheral arterial disease (PAD) in a population-based historical cohort study of patients enrolled in a health maintenance organization. For up

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::168da146cbf81f29450fba315c78848c
https://pubmed.ncbi.nlm.nih.gov/1599350

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání